Dynamic assessment of antiangiogenic therapy by monitoring both tumoral vascularization and tissue degeneration
Open Access
- 31 August 2006
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 14 (2) , 108-117
Abstract
Tumor growth is dependent both on endothelial and tumor cells. The aim of this study was to investigate dynamically whether changes in tumor vasculature implicate tumor tissue degeneration during antiangiogenic therapies. In order to quantify intra-tumor vascularization and necrosis, we have used ultrasound technology. This study has identified essential parameters needed to quantify specifically and sensitively the number of microvessels and the extent of necrosis in xenografted human carcinomas during natural tumor evolution, using contrast-enhanced high-frequency ultrasonography with (HFCDUS) or without (HFUS) color Doppler. We showed that quantification of intra-tumor microvessels between HFCDUS and immunohistochemistry is correlated using an anti-CD31 antibody. Furthermore, quantification of tumor necrosis with HFUS was confirmed by histological examination of hematoxylin–eosin–saffranin-stained sections over the observation period. Subsequently, for the assessment of novel angiogenic inhibitors, HFCDUS and HFUS were used to elucidate the underlying dynamics linking vessel inhibition and tumor eradication. We describe a novel application for HFCDUS/HFUS that constitutes an effective, convenient, and non-invasive method for clinical assessment of angiogenic inhibitors. In conclusion, we showed that tumor cells abruptly became necrotic following an antivascular therapy, whereas untreated tumors were protected from degeneration by a significant blood supply.Keywords
This publication has 43 references indexed in Scilit:
- Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal CancerNew England Journal of Medicine, 2004
- Evidence of Efficacy: Researchers Investigating Markers for Angiogenesis InhibitorsJNCI: Journal of the National Cancer Institute, 2003
- Imaging of angiogenesis: from microscope to clinicNature Medicine, 2003
- Clinical Application of Antiangiogenic Therapy: Microvessel Density, What It Does and Doesn't Tell UsJNCI: Journal of the National Cancer Institute, 2002
- Comparison between `in vivo' and `in vitro' methods for evaluating tumor angiogenesis using cervical carcinoma as a modelAngiogenesis, 1999
- Quantified color Doppler sonography of tumor vascularity in an animal model.Journal of Ultrasound in Medicine, 1999
- Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinomaCell, 1994
- Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast CarcinomaNew England Journal of Medicine, 1991
- Correlation of Doppler US tumor signals with neovascular morphologic features.Radiology, 1988
- Anti-AngiogenesisAnnals of Surgery, 1972